Benchmark Holdings (BMK)

Sector:

Pharma and Biotech

 40.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 48.00p
  • 52 Week Low: 34.00p
  • Currency: UK Pounds
  • Shares Issued: 739.78m
  • Volume: 100,222
  • Market Cap: £295.91m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
31-Mar-24 Interim 80.22 (7.86) (1.21)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-19 124.01 (58.48) (10.72)p n/a n/a n/a n/a 0.0%
30-Sep-20 105.57 (22.57) (3.80)p n/a n/a n/a n/a 0.0%
30-Sep-21 125.06 (9.18) (1.93)p n/a n/a n/a n/a 0.0%
30-Sep-22 157.71 (21.38) (4.34)p n/a n/a n/a n/a 0.0%
30-Sep-23 169.48 (12.69) (2.41)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-24 169.65 7.95 (1.00)p n/a n/a n/a n/a 0.0%
30-Sep-25 189.55 16.35 1.00p 40.0 n/a n/a n/a 0.0%
30-Sep-26 213.20 24.15 1.70p 23.5 0.3 +70% n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

BMK Market Data

Currency UK Pounds
Share Price 40.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 48.00p
52 Week Low 34.00p
Volume 100,222
Shares Issued 739.78m
Market Cap £295.91m

BMK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
27.01% below the market average27.01% below the market average27.01% below the market average27.01% below the market average27.01% below the market average
21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average
Price Trend
25.33% above the market average25.33% above the market average25.33% above the market average25.33% above the market average25.33% above the market average
50.94% above the sector average50.94% above the sector average50.94% above the sector average50.94% above the sector average50.94% above the sector average
Income Not Available
Growth
6.43% above the market average6.43% above the market average6.43% above the market average6.43% above the market average6.43% above the market average
15.15% above the sector average15.15% above the sector average15.15% above the sector average15.15% above the sector average15.15% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

BMK Dividends

No dividends found

Trades for 26-Jun-2024

Time Volume / Share Price
15:11 5,535 @ 40.00p
15:11 5,307 @ 40.00p
15:11 6,025 @ 40.00p
15:11 5,593 @ 40.00p
15:10 5,000 @ 40.00p

BMK Key Personnel

Chair Peter George
CFO Septima Maguire
CEO Trond Williksen

Top of Page